Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT02042911 · COMPLETED
Trial details
- NCT number
- NCT02042911
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.